Based on these results, we found that ITGAV plays a crucial role in the structure and function of the digestive tract, potentially promoting the progression of digestive system cancers by influencing cellular migratory capacity, but more in vivo and in vitro studies are needed in the future to elucidate deeper mechanisms. Here, ITGAV is linked to digestive system cancer.